Emma S Gogarnoiu
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 10
Publications (10 Years): 10
Publications
- Joshua M Paolillo, Alana D Duke, Emma S Gogarnoiu, Dan E Wise, Marvin Parasram
- Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, Alessandro Bonifazi, Elizabeth Saab, Anver Basha Shaik, Omar Soler-Cedeño, Guo-Hua Bi, Benjamin Klein, Zheng-Xiong Xi, J Robert Lane, Amy Hauck Newman
- Joshua M Paolillo, Alana D Duke, Emma S Gogarnoiu, Dan E Wise, Marvin Parasram
- Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, Alessandro Bonifazi, Elizabeth Saab, Anver Basha Shaik, Omar Soler-Cedeño, Guo-Hua Bi, Benjamin Klein, Zheng-Xiong Xi, J Robert Lane, Amy Hauck Newman
- Joshua M Paolillo, Alana D Duke, Emma S Gogarnoiu, Dan E Wise, Marvin Parasram
- Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, Alessandro Bonifazi, Elizabeth Saab, Anver Basha Shaik, Omar Soler-Cedeño, Guo-Hua Bi, Benjamin Klein, Zheng-Xiong Xi, J Robert Lane, Amy Hauck Newman
- Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, Alessandro Bonifazi, Elizabeth Saab, Anver Basha Shaik, Omar Soler-Cedeño, Guo-Hua Bi, Benjamin Klein, Zheng-Xiong Xi, J Robert Lane, Amy Hauck Newman
- Dan E Wise, Emma S Gogarnoiu, Alana D Duke, Joshua M Paolillo, Taylor L Vacala, Waseem A Hussain, Marvin Parasram
- Ewa Galaj, Guo-Hua Bi, Benjamin Klein, Briana Hempel, Anver Basha Shaik, Emma S Gogarnoiu, Jacob Friedman, Jenny Lam, Rana Rais, John F Reed, Shelley H Bloom, Tracy L Swanson, Jennifer L Schmachtenberg, Amy J Eshleman, Aaron Janowsky, Zheng-Xiong Xi, Amy Hauck NewmanA highly D 3 R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D 3 R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 47 (13) (2022)